Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Year-To-Date and Q3 2018 Results
-
Divestment of rights to Alvesco, Omnaris and Zetonna to Covis Pharma
-
The landmark DECLARE-TIMI 58 cardiovascular outcomes trial of Farxiga in patients with type-2 diabetes to be featured at AHA 2018
-
Agreement with Grünenthal for rights to Nexium in Europe and Vimovo worldwide (ex-US)
-
Phase III HARMONIZE Global trial of Lokelma confirms efficacy in maintaining normal potassium levels in Asian patients with hyperkalaemia
-
AstraZeneca strengthens and expands oncology development and commercialisation collaboration with Innate Pharma
-
AstraZeneca to present new data demonstrating breadth of research portfolio in renal disease at ASN Kidney Week 2018
-
SOLO-1 Phase III trial demonstrates Lynparza maintenance therapy cut risk of disease progression or death by 70% in patients with newly-diagnosed, advanced BRCA-mutated ovarian cancer
-
New data on mechanisms of acquired resistance after 1st-line Tagrisso in NSCLC support initiation of ORCHARD trial to explore post-progression treatment options
-
CHMP issues a positive opinion for Bevespi Aerosphere for the treatment of chronic obstructive pulmonary disease
Latest articles and press releases
All of our latest press releases and articles are available to explore
